MAIA Biotechnology Inc’s filing revealed that its Director Smith Stan acquired Company’s shares for reported $0.3 million on Apr 25 ’24. In the deal valued at $2.03 per share,147,492 shares were bought. As a result of this transaction, Smith Stan now holds 1,005,060 shares worth roughly $3.23 million.
Then, Louie Ngar Yee bought 19,665 shares, generating $39,920 in total proceeds. Upon buying the shares at $2.03, the Director now owns 1,167,189 shares.
Before that, Smith Stan bought 170,940 shares. MAIA Biotechnology Inc shares valued at $200,000 were divested by the Director at a price of $1.17 per share. As a result of the transaction, Smith Stan now holds 857,568 shares, worth roughly $2.75 million.
Price Performance Review of MAIA
On Monday, MAIA Biotechnology Inc [AMEX:MAIA] saw its stock jump 9.18% to $3.21. Over the last five days, the stock has gained 42.04%. MAIA Biotechnology Inc shares have risen nearly 174.36% since the year began. Nevertheless, the stocks have risen 34.31% over the past one year. While a 52-week high of $3.07 was reached on 04/29/24, a 52-week low of $0.82 was recorded on 01/16/24. SMA at 50 days reached $1.93, while 200 days put it at $1.75. A total of 0.97 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For MAIA Stock
The 24-hour chart illustrates a support level at 2.93, which if violated will result in even more drops to 2.64. On the upside, there is a resistance level at 3.49. A further resistance level may holdings at 3.76. The Relative Strength Index (RSI) on the 14-day chart is 74.80, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.55, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 16.57%. Stochastics %K at 90.14% indicates the stock is a selling.
